Anti-Cancer Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Anti-Cancer Agents
Volume 21, 18 Issues, 2021
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
Contents
Anti-Cancer Agents in Medicinal Chemistry, Volume 12 - Number 7
Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
, 12(7): 688 - 706Isao Okazaki and Kazuki Nabeshima
DOI: 10.2174/187152012802650200
Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment
, 12(7): 707 - 717Dimitris Stellas and Evangelia Patsavoudi
DOI: 10.2174/187152012802650246
Modulation of MMPs by Cell Surface Integrin Receptor α5β1
, 12(7): 726 - 732Sekhar Pal, Kirat Kumar Ganguly, Shuvojit Moulik and Amitava Chatterjee
DOI: 10.2174/187152012802650183
MicroRNAs in Cancer: Small Molecules, Big Chances
, 12(7): 733 - 743Mohammed Abba, Giridhar Mudduluru and Heike Allgayer
DOI: 10.2174/187152012802650273
Differential Expressions of Matrix Metalloproteinases, A Disintegrin and Metalloproteinases, and a Disintegrin and Metalloproteinases with Thrombospondin Motifs and their Endogenous Inhibitors Among Histologic Subtypes of Lung Cancers
, 12(7): 744 - 752Yasuhiro Hida and Jun-ichi Hamada
DOI: 10.2174/187152012802650156
Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science
, 12(7): 753 - 763Isao Okazaki and Yutaka Inagaki
DOI: 10.2174/187152012802650165
MMPs in Ovarian Cancer as Therapeutic Targets
, 12(7): 764 - 772Amer Karam and Oliver Dorigo
DOI: 10.2174/187152012802650174
Regulation of MMPs During Melanoma Progression: From Genetic to Epigenetic
, 12(7): 773 - 782Frank Antonicelli, David Vallerand, Aurélie Trussardi-Regnier, Florent Grange, William Hornebeck and Philippe Bernard
DOI: 10.2174/187152012802650228
The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro
, 12(7): 783 - 790Dhana E. Larsson, Saadia B. Hassan, Kjell Oberg and Dan Granberg
DOI: 10.2174/187152012802650147
A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
, 12(7): 791 - 800Koshi Kawakami, Miho Hattori, Takatsugu Inoue, Yuriko Maruyama, Junko Ohkanda, Nobuo Kato, Miki Tongu, Takaya Yamada, Miho Akimoto, Keizo Takenaga, Takeshi Sassa, Junji Suzumiy and Yoshio Honma
DOI: 10.2174/187152012802650264
Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition
, 12(7): 801 - 806Jean M. Brunel, Chanaz Salmi-Smail, Audrey Restouin, Thomas Prebet, Norbert Vey and Yves Collette
DOI: 10.2174/187152012802650192
Calculation of Molecular Features with Apparent Impact on Both Activity of Mutagens and Activity of Anticancer Agents
, 12(7): 807 - 817Andrey A. Toropov, Alla P. Toropova, Emilio Benfenati, Giuseppina Gini, Danuta Leszczynska and Jerzy Leszczynski
DOI: 10.2174/187152012802650255
Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice
, 12(7): 818 - 828Zhisong Cao, John Mendoza, Anthony Kozielski, Xing Liu, Albert DeJesus, Yang Wang, Chang-Guo Zhan, Dana Vardeman and Beppino Giovanella
DOI: 10.2174/187152012802650219
Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma
, 12(7): 829 - 834Yoshihiro Yakushijin, Tomiko Tatsukawa, Takumi Yamaguchi, Takashi Egawa, Noriaki Hidaka, Keiko Ido, Katsuya Suemaru, Masaki Yasukawa and Hiroak Araki
DOI: 10.2174/187152012802650138
Editor-in-Chief
Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
(Italy)
Biography
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
Biography
Biography of Simone Carradori
Dr. Simone Carradori, after completing graduation in “Drug Chemistry and Technology”, obtained
his PhD in “Pharmaceutical Sciences” at the University of Rome "La Sapienza" (Italy). He
collaborates with several departments abroad. Currently, he is assistant professor at the Department
of Pharmacy of “G. d’Annunzio” University of Chieti-Pescara (Italy). The scientific activity is
mainly focused on the synthesis and characterization of heterocyclic derivatives as well as
extraction of natural compounds with potential biological activity, and is documented from several
papers in international peer-reviewed journals, one European patent and participations in numerous
conferences.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.
Scopus CiteScore Metrics: 3.5
Webmaster Contact: info@benthamscience.net